Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth A Freedberg

Showing results (201-210 of 325) with videos related to

Pageof 33
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|November 12, 2010
The clinical impact and cost-effectiveness of routine, voluntary HIV screening in South AfricaRochelle P Walensky, Robin Wood, Mariam O Fofana, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 6, 2009
HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectivenessA David Paltiel, Kenneth A Freedberg, Callie A Scott, et al.
The New England Journal of Medicine|September 15, 2006
Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'IvoireSue J Goldie, Yazdan Yazdanpanah, Elena Losina, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 13, 2017
Projecting 10-year, 20-year, and Lifetime Risks of Cardiovascular Disease in Persons Living With Human Immunodeficiency Virus in the United StatesElena Losina, Emily P Hyle, Ethan D Borre, et al.
Annals of Internal Medicine|December 5, 2012
Efficacy of a clinical decision-support system in an HIV practice: a randomized trialGregory K Robbins, William Lester, Kristin L Johnson, et al.
Annals of Internal Medicine|April 2, 2019
Risks and Benefits of Dolutegravir- and Efavirenz-Based Strategies for South African Women With HIV of Child-Bearing Potential: A Modeling StudyCaitlin M Dugdale, Andrea L Ciaranello, Linda-Gail Bekker, et al.
Antiviral Therapy|July 20, 2012
Could early antiretroviral therapy entail more risks than benefits in sub-Saharan African HIV-infected adults? A model-based analysisXavier Anglaret, Callie A Scott, Rochelle P Walensky, et al.
Plos One|August 17, 2023
The association between all-cause mortality and HIV acquisition risk groups in the United States, 2001-2014Fatma M Shebl, Yiqi Qian, Julia H A Foote, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 27, 2005
Cost-effectiveness of enfuvirtide in treatment-experienced patients with advanced HIV diseasePaul E Sax, Elena Losina, Milton C Weinstein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2012
The cost-effectiveness of pre-exposure prophylaxis for HIV infection in South African womenRochelle P Walensky, Ji-Eun Park, Robin Wood, et al.
Pageof 33

Showing results (201-210 of 325) with videos related to

Sort By:
Pageof 33
Journal of Acquired Immune Deficiency Syndromes (1999)|November 12, 2010
The clinical impact and cost-effectiveness of routine, voluntary HIV screening in South AfricaRochelle P Walensky, Robin Wood, Mariam O Fofana, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 6, 2009
HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectivenessA David Paltiel, Kenneth A Freedberg, Callie A Scott, et al.
The New England Journal of Medicine|September 15, 2006
Cost-effectiveness of HIV treatment in resource-poor settings--the case of Côte d'IvoireSue J Goldie, Yazdan Yazdanpanah, Elena Losina, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 13, 2017
Projecting 10-year, 20-year, and Lifetime Risks of Cardiovascular Disease in Persons Living With Human Immunodeficiency Virus in the United StatesElena Losina, Emily P Hyle, Ethan D Borre, et al.
Annals of Internal Medicine|December 5, 2012
Efficacy of a clinical decision-support system in an HIV practice: a randomized trialGregory K Robbins, William Lester, Kristin L Johnson, et al.
Annals of Internal Medicine|April 2, 2019
Risks and Benefits of Dolutegravir- and Efavirenz-Based Strategies for South African Women With HIV of Child-Bearing Potential: A Modeling StudyCaitlin M Dugdale, Andrea L Ciaranello, Linda-Gail Bekker, et al.
Antiviral Therapy|July 20, 2012
Could early antiretroviral therapy entail more risks than benefits in sub-Saharan African HIV-infected adults? A model-based analysisXavier Anglaret, Callie A Scott, Rochelle P Walensky, et al.
Plos One|August 17, 2023
The association between all-cause mortality and HIV acquisition risk groups in the United States, 2001-2014Fatma M Shebl, Yiqi Qian, Julia H A Foote, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 27, 2005
Cost-effectiveness of enfuvirtide in treatment-experienced patients with advanced HIV diseasePaul E Sax, Elena Losina, Milton C Weinstein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2012
The cost-effectiveness of pre-exposure prophylaxis for HIV infection in South African womenRochelle P Walensky, Ji-Eun Park, Robin Wood, et al.
Pageof 33